The rapidly evolving diagnosis and treatment of age-related  macular degeneration.
Breakthrough research on age-related macular degeneration is stimulating the development of treatments, improving diagnosis, facilitating prevention through proper nutrition, and providing long-sought documentation on the effectiveness of low vision rehabilitation.Optometrists must take the lead in ensuring that patients reap the benefits. The February observance of Age-Related Macular Degeneration (AMD)/Low Vision Awareness Month provides a good time for optometrists to review their approach to age-related vision loss,ensure that they are ready to provide, or refer patients for, the best possible care, and prepare to conduct education efforts to ensure that their patients, communities, and other healthcare providers are aware of recent advancements.
D006801:Humans; D053685:Laser Therapy; D008268:Macular Degeneration / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D009885:Ophthalmology / Q000639:trends*; D010778:Photochemotherapy; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014786:Vision Disorders / Q000209:etiology / Q000534:rehabilitation
D042461:Vascular Endothelial Growth Factor A